BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Biotech Beach

  Precision Biologics, A Nantworks Company, To Present Combination Immunotherapy Of A Novel Neo-Epitope Antibody Targeting Ovarian And Uterine Cancer At The AACR Annual Meeting 2016

  April 18, 2016

   · 

  4 min read
• Drug Development

  AstraZeneca PLC Presents DNA Damage Response Science At The AACR 2016 Annual Meeting

  April 18, 2016

   · 

  7 min read
• Genetown

  Jounce Presents Data Highlighting Advances From Two Programs In Its Immuno-Oncology Pipeline At The 2016 AACR Annual Meeting

  April 18, 2016

   · 

  4 min read
• Business

  Tauriga Sciences Inc. Appoints Mr. Keith M. Berman As A Member Of The Company’s Board Of Directors

  April 18, 2016

   · 

  3 min read
• Business

  Span-America Medical Systems, Inc. To Release Second Quarter Fiscal 2016 Results On May 5, 2016

  April 18, 2016

   · 

  1 min read
• Pharm Country

  Amplification Technologies Corp. Announces New Eye-Safe Discrete Amplification Geiger-Mode Arrays For 3D LIDAR Applications

  April 18, 2016

   · 

  4 min read
• Business

  Freeline Therapeutics Acquires Munich-Based Manufacturing Technology Platform And Has Appointed Dr Markus Hörer As Chief Technology Officer

  April 18, 2016

   · 

  3 min read
• Business

  ImmunoBiochem Corporation Partners With The Centre For The Commercialization Of Antibodies And Biologics At The University of Toronto To Advance New Antibody Drug Conjugates

  April 18, 2016

   · 

  5 min read
• Business

  Vitruvias Therapeutics And Sunny Pharmtech Expand Partnership To Co-Develop Additional High Value Generic Drugs

  April 18, 2016

   · 

  2 min read
• Drug Development

  Merus To Present Interim Clinical Data From Ongoing Phase I/II Clinical Trial Of Its Lead Bispecific Antibody Candidate, MCLA-128, At The AACR 2016 Annual Meeting

  April 18, 2016

   · 

  4 min read